샘플 요청 목록

 카트 문의
시장보고서
상품코드
1591417

세계의 저분자 Drug Discovery 시장 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 치료 분야별, 공정/단계별, 지역별

Small Molecule Drug Discovery Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapeutic Area, Process/Phase, and Geography
발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 140 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

저분자 Drug Discovery 시장은 2023년 509억 3,000만 달러에서 2031년까지 1,067억 7,000만 달러에 달할 것으로 예상되며, 2023년부터 2031년까지 9.7%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. R&D 활동의 급증과 아웃소싱 지향 증가로 인한 제약 산업의 번영이 저분자 Drug Discovery 시장의 성장에 기여하고 있습니다. 그러나 높은 신약 개발 비용은 시장 개척에 걸림돌로 작용하고 있습니다. 또한, 신약개발에 있어 인공지능의 도입 확대는 향후 몇 년동안 저분자 Drug Discovery 시장의 새로운 트렌드를 가져올 것으로 예상됩니다.

2023년 세계 저분자 Drug Discovery 시장에서 북미가 큰 비중을 차지할 것으로 예상됩니다. 북미 저분자 Drug Discovery 시장은 미국, 캐나다, 멕시코로 구분됩니다. 제약사 및 생명공학 기업의 신약 개발을 위한 연구개발 증가, 의약품에 대한 투자 확대, 암의 확산 등은 북미 저분자 Drug Discovery 시장의 성장을 가속화할 것으로 예측되는 요인 중 하나입니다. 미국은 북미에서 가장 발전된 국가 중 하나입니다. 주로 심혈관 질환과 암과 같은 만성 질환의 유병률 증가가 시장 성장을 주도하고 있습니다. 미국 암협회에 따르면, 2024년에는 200만 명이 새로운 암에 걸리고 61만 1,000명이 사망할 것으로 예상되고 있습니다. 이에 따라 미국 의료 시스템은 새로운 약물 분자 연구개발에 많은 투자를 하고 있습니다. 또한, 강력한 의약품 파이프라인과 저분자 의약품의 치료 영역 승인이 이 지역 시장을 견인할 것으로 예상됩니다. 승인된 의약품의 수 증가와는 별개로, 첨단 치료법에 대한 인식 증가는 예측 기간 동안 저분자 Drug Discovery 시장의 성장 요인으로 작용할 것으로 보입니다.

캐나다 저분자 Drug Discovery 시장의 성장은 정부 이니셔티브 증가, 암 발병률 증가, 주요 기업의 전략적 이니셔티브에 기인합니다. 캐나다에서는 다양한 질병을 치료할 수 있는 혁신적인 치료 옵션을 이용할 수 있습니다. 캐나다 의료 분야에서 저분자 의약품의 채택이 증가하고 있으며, 향후 몇 년동안 시장 성장을 가속할 가능성이 높습니다.

캐나다 정부의 발표에 따르면, 캐나다는 매출액 기준 세계 9위의 의약품 시장입니다. 혁신적인 제약회사, 제약회사, 제약회사, CRO, 중소형 바이오제약회사 등이 이러한 막대한 매출을 창출하고 있으며, Statistics Canada 2020에 따르면 캐나다에는 6,280개의 제약회사가 진출해있다고 합니다. 제약 부문은 그 중 41%를 차지하고 있으며, 연구개발 부문은 전체 헬스케어 부문의 31%를 차지하고 있습니다. 이처럼 급성장하는 제약 및 바이오 의약품 산업은 캐나다에서 저분자 Drug Discovery에 대한 큰 수요를 창출하고 있습니다.

저분자 기반 파이프라인 증가는 향후 시장 기회를 가져올 것입니다.

제약 산업은 끊임없이 진화하고 있으며, 다양한 만성 질환을 치료할 수 있는 새롭고 혁신적인 치료법이 끊임없이 요구되고 있습니다. 저분자 의약품은 다양한 적응증에 효과적이기 때문에 지난 5년간 승인 건수가 증가하고 있습니다. 저분자 의약품 후보물질을 기반으로 한 파이프라인은 암, 고혈압, 당뇨병, 염증성 질환 등 다양한 치료 분야에서 성장하고 있습니다. 많은 크고 작은 제약회사들이 여러 저분자 의약품을 개발하기 위해 노력하고 있습니다.

다양한 적응증에 대한 저분자 의약품 파이프라인 증가는 업계 전반의 신약 개발 활동을 촉진하고 있습니다.

저분자 Drug Discovery 시장 : 경쟁 구도와 주요 발전

Bristol-Myers Squibb Co, Merck KGaA, GSK Plc, Boehringer Ingelheim International GmbH, Thermo Fisher Scientific Inc, ICON Plc, Danaher Corp, Charles River Laboratories International Inc, Oncodesign Services, Revvity Inc 등이 저분자 Drug Discovery 시장에서 활동하는 주요 기업입니다.

US Food and Drug Administration, Centers for Disease Control and Prevention(CDC), Center for the Study of Drug Development 등은 저분자 Drug Discovery 시장 보고서 작성 시 참고한 1차 및 2차 정보 중 하나입니다.

목차

제1장 서론

제2장 주요 요약

  • 주요 인사이트

제3장 조사 방법

  • 2차 조사
  • 1차 조사
    • 가설 책정
    • 거시경제 요인 분석
    • 기초 수치 작성
    • 데이터 삼각측량
    • 국가 레벨 데이터

제4장 저분자 Drug Discovery 시장 구도

  • 개요
  • PEST 분석

제5장 저분자 Drug Discovery 시장 : 주요 시장 역학

  • 저분자 Drug Discovery 시장 : 주요 시장 역학
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 동향
  • 성장 촉진요인과 억제요인의 영향

제6장 저분자 Drug Discovery 시장 : 세계 시장 분석

  • 저분자 Drug Discovery 시장 판매량, 2021년-2031년
  • 저분자 Drug Discovery 시장 예측 분석

제7장 저분자 Drug Discovery 시장 분석 : 치료 분야별

  • 종양학
  • 중추신경계
  • 심혈관
  • 호흡기
  • 정형외과
  • 면역학
  • 희귀질환
  • 기타 치료 영역

제8장 저분자 Drug Discovery 시장 분석 : 프로세스/단계별

  • 표적 발견
  • 표적 검증
  • 리드 생성 및 구체화
  • 전임상 개발

제9장 저분자 Drug Discovery 시장 : 지역별 분석

  • 북미
    • 북미
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양
      • 일본
      • 중국
      • 인도
      • 한국
      • 호주
      • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카
      • 사우디아라비아
      • 아랍에미리트(UAE)
      • 남아프리카공화국
      • 기타 중동 및 아프리카
  • 중남미
    • 중남미
      • 브라질
      • 아르헨티나
      • 기타 중남미

제10장 업계 상황

제11장 기업 개요

  • Bristol-Myers Squibb Co.
  • Merck KGaA.
  • GSK Plc.
  • Thermo Fisher Scientific Inc.
  • ICON Plc.
  • Danaher Corp.
  • Charles River Laboratories International Inc.
  • Oncodesign Services.
  • Revvity Inc.
  • Boehringer Ingelheim International GmbH.

제12장 부록

LSH 24.11.28

The Small Molecule Drug Discovery market is anticipated to grow from US$ 50.93 billion in 2023 and is projected to reach US$ 106.77 billion by 2031; it is expected to register a CAGR of 9.7% during 2023-2031. Flourishing pharmaceutical industry with surge in R&D activities and growing inclination toward outsourcing are contributing to the small molecule drug discovery market growth. However, high drug development costs hamper market growth. Further, the growing adoption of artificial intelligence in drug discovery is expected to bring new small molecule drug discovery market trends in the coming years.

North America accounted for a major share of the global small molecule drug discovery market in 2023. The North America small molecule drug discovery market is segmented into the US, Canada, and Mexico. Increasing research and development by pharmaceutical and biotechnology companies in discovering novel drugs, growing investments in pharmaceuticals, and prevalence of cancer are among the factors that are projected to accelerate the growth of the North America small molecule drug discovery market. The US is one of the most developed countries in North America. The increasing prevalence of chronic diseases such as cardiovascular diseases and cancer primarily drives the market growth in the country. As per the American Cancer Society, in 2024, ~2 million people are projected to suffer from new cancer cases, and ~611,000 death cases are expected to be registered in the US. Owing to this scenario, the US health system witnesses massive investments in research and developments for novel drug molecules. Further, a strong drug pipeline, along with therapeutic area approvals for small molecule drugs, is expected to drive the regional market. Apart from the rising number of approved drugs, increasing awareness of advanced therapeutics is likely to be responsible for the growth of the small molecule drug discovery market during the forecast period.

The growth of the Canada small molecule drug discovery market is attributed to increasing government initiatives and growing cancer prevalence, as well as strategic initiatives by the major players. Canadians are able to deal with a variety of medical conditions due to the availability of innovative treatment options. The rising adoption of small molecule medicines in Canadian healthcare is likely to continue to boost the market growth over the coming years.

As per the Government of Canada, the country ranks ninth among the largest pharmaceutical markets in the world in terms of sales value. Innovative pharmaceutical companies, drug manufacturers, contract research organizations (CROs), and small- and medium-sized biopharmaceutical companies are among the major enablers of such a huge sales value. According to Statistics Canada 2020, 6,280 companies were operating in Canada. The pharmaceutical sector accounts for 41%, and the research and development sector accounts for 31% of its overall healthcare sector. Thus, the rapidly growing pharmaceutical and biopharmaceutical industries generate a huge demand for small molecule drug discovery in Canada.

Increasing Small Molecule-Based Pipeline to Provide Market Opportunities in Future

The pharmaceutical industry is continually evolving and there is always a need for new, innovative therapeutic approaches in the treatment of various chronic indications. Small molecule-based drug approvals have been increased in the past five years owing to their effectiveness against a wide range of indications. Small molecule drug candidate-based pipelines are growing for a wide range of therapeutic applications, including oncology, hypertension, diabetes, and inflammatory disorders. Many big and small pharmaceutical companies are engaged in the development of several small-molecule drugs.

The growing pipeline of small molecule-based drugs for various indications is, in turn, boosting drug discovery activities across the industry.

Small Molecule Drug Discovery Market: Competitive Landscape and Key Developments

Bristol-Myers Squibb Co, Merck KGaA, GSK Plc, Boehringer Ingelheim International GmbH, Thermo Fisher Scientific Inc, ICON Plc, Danaher Corp, Charles River Laboratories International Inc, Oncodesign Services, and Revvity Inc are among the key companies operating in the small molecule drug discovery market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Centre for the Study of Drug Development are among the primary and secondary sources referred to while preparing the small molecule drug discovery market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance.
  • 1.2 Market Segmentation.

2. Executive Summary

  • 2.1 Key Insights.

3. Research Methodology

  • 3.1 Secondary Research.
  • 3.2 Primary Research.
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.1 Developing base number:
    • 3.2.2 Data Triangulation:
    • 3.2.3 Country level data:

4. Small Molecule Drug Discovery Market Landscape

  • 4.1 Overview.
  • 4.2 PEST Analysis.

5. Small Molecule Drug Discovery Market - Key Market Dynamics

  • 5.1 Small Molecule Drug Discovery Market - Key Market Dynamics.
  • 5.2 Market Drivers.
    • 5.2.1 Flourishing Pharmaceutical Industry with Surge in R&D Activities.
    • 5.2.2 Growing Inclination Toward Outsourcing.
  • 5.3 Market Restraints.
    • 5.3.1 High Drug Development Cost
  • 5.4 Market Opportunities.
    • 5.4.1 Increasing Small Molecule-Based Pipeline.
  • 5.5 Future Trends.
    • 5.5.1 Growing Adoption of Artificial Intelligence in Drug Discovery.
  • 5.6 Impact of Drivers and Restraints:

6. Small Molecule Drug Discovery Market - Global Market Analysis

  • 6.1 Small Molecule Drug Discovery Market Revenue (US$ Million), 2021-2031.
  • 6.2 Small Molecule Drug Discovery Market Forecast Analysis.

7. Small Molecule Drug Discovery Market Analysis - by Therapeutic Area

  • 7.1 Oncology.
    • 7.1.1 Overview.
    • 7.1.2 Oncology: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Central Nervous System..
    • 7.2.1 Overview.
    • 7.2.2 Central Nervous System: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Cardiovascular
    • 7.3.1 Overview.
    • 7.3.2 Cardiovascular: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Respiratory.
    • 7.4.1 Overview.
    • 7.4.2 Respiratory: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Orthopedics.
    • 7.5.1 Overview.
    • 7.5.2 Orthopedics: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Immunology.
    • 7.6.1 Overview.
    • 7.6.2 Immunology: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Rare Diseases.
    • 7.7.1 Overview.
    • 7.7.2 Rare Diseases: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.8 Other Therapeutic Areas.
    • 7.8.1 Overview.
    • 7.8.2 Other Therapeutic Areas: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)

8. Small Molecule Drug Discovery Market Analysis - by Process or Phase

  • 8.1 Target Discovery.
    • 8.1.1 Overview.
    • 8.1.2 Target Discovery: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Target Validation.
    • 8.2.1 Overview.
    • 8.2.2 Target Validation: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Lead Generation and Refinement
    • 8.3.1 Overview.
    • 8.3.2 Lead Generation and Refinement: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Preclinical Development
    • 8.4.1 Overview.
    • 8.4.2 Preclinical Development: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)

9. Small Molecule Drug Discovery Market - Geographical Analysis

  • 9.1 North America.
    • 9.1.1 North America Small Molecule Drug Discovery Market Overview.
    • 9.1.2 North America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.1.3 North America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.1.4 North America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.1.5 North America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.1.5.1 United States: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.5.1.1 United States: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.1.5.1.2 United States: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.1.5.2 Canada: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.5.2.1 Canada: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.1.5.2.2 Canada: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.1.5.3 Mexico: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.5.3.1 Mexico: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.1.5.3.2 Mexico: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
  • 9.2 Europe
    • 9.2.1 Europe Small Molecule Drug Discovery Market Overview.
    • 9.2.2 Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.2.3 Europe: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.2.4 Europe: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.2.5 Europe: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.2.5.1 Germany: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.1.1 Germany: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.1.2 Germany: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.2 France: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.2.1 France: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.2.2 France: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.3 United Kingdom: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.3.1 United Kingdom: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.3.2 United Kingdom: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.4 Italy: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.4.1 Italy: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.4.2 Italy: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.5 Spain: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.5.1 Spain: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.5.2 Spain: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.6 Rest of Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.6.1 Rest of Europe: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.6.2 Rest of Europe: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
  • 9.3 Asia Pacific.
    • 9.3.1 Asia Pacific Small Molecule Drug Discovery Market Overview.
    • 9.3.2 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.3.3 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.3.4 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.3.5 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.3.5.1 Japan: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.1.1 Japan: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.1.2 Japan: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.2 China: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.2.1 China: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.2.2 China: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.3 India: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.3.1 India: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.3.2 India: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.4 South Korea: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.4.1 South Korea: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.4.2 South Korea: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.5 Australia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.5.1 Australia: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.5.2 Australia: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.6 Rest of APAC: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.6.1 Rest of APAC: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.6.2 Rest of APAC: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
  • 9.4 Middle East & Africa.
    • 9.4.1 Middle East & Africa Small Molecule Drug Discovery Market Overview.
    • 9.4.2 Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.4.3 Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.4.4 Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.4.5 Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.4.5.1 Saudi Arabia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.5.1.1 Saudi Arabia: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.4.5.1.2 Saudi Arabia: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.4.5.2 United Arab Emirates: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.5.2.1 United Arab Emirates: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.4.5.2.2 United Arab Emirates: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.4.5.3 South Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.5.3.1 South Africa: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.4.5.3.2 South Africa: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.4.5.4 Rest of Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.5.4.1 Rest of Middle East & Africa: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.4.5.4.2 Rest of Middle East & Africa: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
  • 9.5 South & Central America.
    • 9.5.1 South & Central America Small Molecule Drug Discovery Market Overview.
    • 9.5.2 South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.5.3 South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.5.4 South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.5.5 South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.5.5.1 Brazil: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.5.1.1 Brazil: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.5.5.1.2 Brazil: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.5.5.2 Argentina: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.5.2.1 Argentina: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.5.5.2.2 Argentina: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.5.5.3 Rest of South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.5.3.1 Rest of South & Central America: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.5.5.3.2 Rest of South & Central America: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.

10. Industry Landscape

  • 10.1 Overview.

11. Company Profiles

  • 11.1 Bristol-Myers Squibb Co.
    • 11.1.1 Key Facts.
    • 11.1.2 Business Description.
    • 11.1.3 Products and Services.
    • 11.1.4 Financial Overview.
    • 11.1.5 SWOT Analysis.
    • 11.1.6 Key Developments.
  • 11.2 Merck KGaA.
    • 11.2.1 Key Facts.
    • 11.2.2 Business Description.
    • 11.2.3 Products and Services.
    • 11.2.4 Financial Overview.
    • 11.2.5 SWOT Analysis.
    • 11.2.6 Key Developments.
  • 11.3 GSK Plc.
    • 11.3.1 Key Facts.
    • 11.3.2 Business Description.
    • 11.3.3 Products and Services.
    • 11.3.4 Financial Overview.
    • 11.3.5 SWOT Analysis.
    • 11.3.6 Key Developments.
  • 11.4 Thermo Fisher Scientific Inc.
    • 11.4.1 Key Facts.
    • 11.4.2 Business Description.
    • 11.4.3 Products and Services.
    • 11.4.4 Financial Overview.
    • 11.4.5 SWOT Analysis.
    • 11.4.6 Key Developments.
  • 11.5 ICON Plc.
    • 11.5.1 Key Facts.
    • 11.5.2 Business Description.
    • 11.5.3 Products and Services.
    • 11.5.4 Financial Overview.
    • 11.5.5 SWOT Analysis.
    • 11.5.6 Key Developments.
  • 11.6 Danaher Corp.
    • 11.6.1 Key Facts.
    • 11.6.2 Business Description.
    • 11.6.3 Products and Services.
    • 11.6.4 Financial Overview.
    • 11.6.5 SWOT Analysis.
    • 11.6.6 Key Developments.
  • 11.7 Charles River Laboratories International Inc.
    • 11.7.1 Key Facts.
    • 11.7.2 Business Description.
    • 11.7.3 Products and Services.
    • 11.7.4 Financial Overview.
    • 11.7.5 SWOT Analysis.
    • 11.7.6 Key Developments.
  • 11.8 Oncodesign Services.
    • 11.8.1 Key Facts.
    • 11.8.2 Business Description.
    • 11.8.3 Products and Services.
    • 11.8.4 Financial Overview.
    • 11.8.5 SWOT Analysis.
    • 11.8.6 Key Developments.
  • 11.9 Revvity Inc.
    • 11.9.1 Key Facts.
    • 11.9.2 Business Description.
    • 11.9.3 Products and Services.
    • 11.9.4 Financial Overview.
    • 11.9.5 SWOT Analysis.
    • 11.9.6 Key Developments.
  • 11.10 Boehringer Ingelheim International GmbH.
    • 11.10.1 Key Facts.
    • 11.10.2 Business Description.
    • 11.10.3 Products and Services.
    • 11.10.4 Financial Overview.
    • 11.10.5 SWOT Analysis.
    • 11.10.6 Key Developments.

12. Appendix

  • 12.1 About The Insight Partners.
  • 12.2 Glossary of Terms.
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제